ストックスクリーナーアプリを入手
10.16
0.12%
-0.0126
前日終値:
$10.17
開ける：
$10.1574
24時間の取引高:
267
Relative Volume:
0.06
時価総額：
$565.77M
収益：
-
当期純損益:
-
株価収益率:
-5.3743
EPS:
-1.89
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+0.12%
1か月 パフォーマンス:
-0.32%
6か月 パフォーマンス:
-80.46%
1年 パフォーマンス:
-80.46%
1日の値動き範囲:
$10.16
$10.16
1週間の範囲:
$10.09
$10.40
52週間の値動き範囲:
$10.07
$10.45
Churchill Capital Corp Xi Stock (CCXI) Company Profile
Compare CCXI vs LION, XXI, DMII, BCSS, EVAC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CCXI
Churchill Capital Corp Xi
|
10.16 | 565.77M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
9.22 | 2.68B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
7.16 | 2.48B | 0 | 4.35M | 456.40K | 0.3397 |
DMII
Drugs Made In America Acquisition Ii Corp
|
9.97 | 653.78M | 0 | 0 | 0 | -0.0028 |
BCSS
Bain Capital Gss Investment Corp
|
10.09 | 589.26M | 0 | 0 | 0 | -0.0013 |
EVAC
Eqv Ventures Acquisition Corp Ii
|
10.07 | 588.57M | 0 | 0 | 0 | 0.0737 |
Churchill Capital Corp Xi Stock (CCXI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-10-11 | アップグレード | JP Morgan | Underweight → Neutral |
| 2021-10-11 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2021-10-08 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-10-08 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2021-07-07 | アップグレード | Stifel | Hold → Buy |
| 2021-05-07 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-05-07 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-05-07 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2021-05-07 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2021-05-07 | ダウングレード | Stifel | Buy → Hold |
| 2021-03-02 | 繰り返されました | H.C. Wainwright | Buy |
| 2021-03-02 | 開始されました | Stifel | Buy |
| 2020-10-29 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-06-17 | 開始されました | BTIG Research | Buy |
| 2020-05-27 | 開始されました | Wells Fargo | Overweight |
| 2020-05-12 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-01-24 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-26 | 繰り返されました | Piper Jaffray | Overweight |
| 2019-03-27 | アップグレード | B. Riley FBR | Neutral → Buy |
| 2019-02-11 | 開始されました | Piper Jaffray | Overweight |
| 2018-09-07 | 開始されました | B. Riley FBR | Neutral |
| 2018-08-14 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2018-06-28 | 開始されました | Raymond James | Strong Buy |
| 2018-05-02 | 開始されました | H.C. Wainwright | Buy |
| 2017-02-21 | 開始されました | JMP Securities | Mkt Outperform |
| 2015-05-18 | アップグレード | JP Morgan | Neutral → Overweight |
| 2013-05-20 | 繰り返されました | Stifel | Buy |
| 2012-11-14 | 開始されました | Stifel Nicolaus | Buy |
すべてを表示
Churchill Capital Corp Xi (CCXI) 最新ニュース
GigCapital9 Corp.: Performance & Quotes, GIX Stock Price on Nasdaq Exchange - marketscreener.com
Churchill Sponsor Xi Llc Net Worth (2026) - GuruFocus
Churchill Capital Corp XI Files Form 8-K Announcing Director Appointment and Company Details - Minichart
Paul Lapping and Stephen Murphy join Churchill board; Lapping named Audit Committee chair - TradingView
Free float of Churchill Capital Corp XI – NASDAQ:CCXIW - TradingView
CCXI Price History for Churchill Capital Corp Xi Cl A Stock - Barchart
Art Technology Acquisition Corp.: Performance & Quotes, ARTC Stock Price on Nasdaq Exchange - marketscreener.com
SPACSphere Acquisition Corp.: Performance & Quotes, SSAC Stock Price on Nasdaq Exchange - marketscreener.com
Soren Acquisition Corp.: Performance & Quotes, SORN Stock Price on Nasdaq Exchange - marketscreener.com
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
CMII|Columbus Circle Capital II Units|Price:9.950|Chg%:0.10 - TradingKey
CCXI Technical Analysis & Stock Price Forecast - Intellectia AI
MML Acquisition Stock (MML.H)Quote Toronto S.E. - marketscreener.com
MML Acquisition: Dividend historical data and projections - marketscreener.com
White Pearl Acquisition Corp.: Performance & Quotes, WPAC Stock Price on Nyse Exchange - marketscreener.com
Eagle Nuclear Energy Corp.: Dividend historical data and projections - marketscreener.com
Eagle Nuclear Energy Corp.: Shareholders Board Members Managers and Company Profile | US2697101093 - marketscreener.com
Eagle Nuclear Energy Corp.: Performance & Quotes, NUCL Stock Price on Nasdaq Exchange - marketscreener.com
Mountain Lake Acquisition Corp.: Dividend historical data and projections - marketscreener.com
Lake Superior Acquisition Corp.: Dividend historical data and projections - marketscreener.com
Free float of Churchill Capital Corp XI – BOATS:CCXIW - TradingView
MML Acquisition Corp.: Dividend historical data and projections - marketscreener.com
Churchill Capital Corp XIUnits (NQ: CCXIU - The Chronicle-Journal
Trailblazer Holdings, Inc.: Dividend historical data and projections - marketscreener.com
Magnetar Financial LLC Acquires 2,700,000 Shares in Churchill Ca - GuruFocus
DermTech Stock (DMTK)Quote OTC Markets - marketscreener.com
Quantum Computing Stocks: Infleqtion Pops In First Day As Public Company - Investor's Business Daily
CCXI Forecast — Price Prediction for 2026. Should I Buy CCXI? - Intellectia AI
CCXIW Stock Price, News & Analysis - Stock Titan
Churchill Capital Corp XI(NasdaqGM: CCXI) added to NASDAQ Composite Index - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
Churchill Capital’s 47% plunge validates InvestingPro’s overvaluation alert By Investing.com - Investing.com Australia
Churchill Capital Corp XI Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing February 9, 2026 - The Manila Times
Churchill Capital Corp XI Announces Separate Trading of Shares and Warrants - TradingView
US FDA Review Team Split On Amgen’s Tavneos Years Before Withdrawal Request - Citeline News & Insights
Asking Amgen to withdraw Tavneos, FDA revisits years-old data issue - BioCentury
Amgen thumbs-down on FDA’s ask, Tavneos sales continue - BioWorld MedTech
Amgen resists FDA request to pull rare disease drug Tavneos from the market - Fierce Pharma
Amgen’s Revenue Gains Outweigh News That FDA Wants Tavneos Pulled From Market - Citeline News & Insights
Amgen Defends Tavneos Benefit-Risk Profile Following FDA Withdrawal Request - Medical Professionals Reference
US FDA Wants Tavneos Pulled From Market, Amgen Declines - Citeline News & Insights
EMA reviewing Amgen’s vasculitis drug over trial ‘data integrity’ - BioWorld MedTech
Horizon (HRZN) and Monroe Capital (MRCC) outline proxy drive for proposed merger and asset sale - Stock Titan
1 km lidar partnership for safer cars, trains and transport systems - Stock Titan
Rough Price Target for a Promising Quantum Computing Name Working With Nvidia - TheStreet Pro
CCCXChurchill Cap Corp X Latest Stock News & Market Updates - Stock Titan
Churchill Capital Corp X (CCCX) Stock News on Dec. 24, 2025: Infleqtion Quantum SPAC Deal, Latest Catalysts, and What Comes Next - TechStock²
Churchill Capital Corp XI completes $414 million IPO and private placement - Investing.com
Infleqtion Chief Scientist for Quantum Information Dr. Mark Saffman Awarded the John Stewart Bell Prize - 01net
White & Case advises the sole bookrunning manager on Churchill Capital Corp XI’s US$414 million upsized IPO - White & Case
Churchill Capital Corp XI closes upsized $414 million IPO - Investing.com
Churchill Capital Corp Xi (CCXI) 財務データ
Churchill Capital Corp Xi (CCXI) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
20.05%
0.10%
大文字化:
|
ボリューム (24 時間):